Identification of an effective early signaling signature during neo-vasculogenesis in vivo by ex vivo proteomic profiling.
Therapeutic neo-vasculogenesis in vivo can be achieved by the co-transplantation of human endothelial colony-forming progenitor cells (ECFCs) with mesenchymal stem/progenitor cells (MSPCs). The underlying mechanism is not completely understood thus hampering the development of novel stem cell therap...
Guardado en:
Autores principales: | Rokhsareh Rohban, Andreas Reinisch, Nathalie Etchart, Katharina Schallmoser, Nicole A Hofmann, Krisztina Szoke, Jan E Brinchmann, Ehsan Bonyadi Rad, Eva Rohde, Dirk Strunk |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e32f1bd324f1475ca2662e7ec725e4fc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivo.
por: Nicole A Hofmann, et al.
Publicado: (2012) -
Cerebral vasculogenesis in rat newborns
por: MR Nik Ravesh, et al.
Publicado: (2005) -
Heparin and Derivatives for Advanced Cell Therapies
por: Sandra Laner-Plamberger, et al.
Publicado: (2021) -
Manganese ferrite-based nanoparticles induce ex vivo, but not in vivo, cardiovascular effects
por: Nunes ADC, et al.
Publicado: (2014) -
A Correlative Imaging Study of in vivo and ex vivo Biodistribution of Solid Lipid Nanoparticles
por: Mannucci S, et al.
Publicado: (2020)